Bayer Access Programs

Eylea^® (aflibercept) 8mg Access Program

From 1st October 2024, Eylea 8mg (aflibercept) is available on the Pharmaceutical Benefits Scheme (PBS). The Eylea 8mg Access program is now closed.

Welcome! Login to your account

Username

Please provide a valid username

Password

Please provide a valid password

Address

Bayer Australia Ltd, ABN 22 000 138 714,
875 Pacific Highway, Pymble, NSW 2073.

MA-AFL_8mg-AU-0024 - 2 September 2024

PBS Information: EYLEA 8 mg: Authority required for the treatment of wet age-related macular degeneration and diabetic macular oedema. EYLEA 2 mg: Authority required for the treatment of wet age-related macular degeneration, diabetic macular oedema, central retinal vein occlusion and branch retinal vein occlusion, myopic choroidal neovascularisation. Refer to PBS schedule for full Authority Required

Please review the product information before prescribing Eylea.
available here.

Adverse Event

To report an adverse event, relevant safety event or quality complaint, please email Atlantis Health on orders.eylea@atlantishealth.com within 1 business day of awareness. See Resources called Adverse Event Reporting for definitions of adverse event, relevant safety event and quality complaint.

This website is intended for Healthcare Professionals only.

Powered by

Privacy Statement
General Conditions of Use
Imprint
Terms of Service
Contact us

You are about to leave this website and are being redirected to the Bayer Australia Ltd website.

Please click OK to proceed.

2mg 6-month Patient Review

Continuing supply – Please continue the ongoing supply of Eylea (aflibercept) Required field

Discontinuing supply – Please discontinue the ongoing supply of Eylea (aflibercept) Required field

From 1st October 2024, Eylea 8mg (aflibercept) is available on the Pharmaceutical Benefits Scheme (PBS).

Please contact your patients as soon as possible to transition them to PBS supply.

If you have any questions, please contact Atlantis Health on 1800 460 150 or email orders.eylea@atlantishealth.com.

You are about to leave this website. The site you are accessing is independent and provided for your convenience. Its content is not controlled by Bayer Australia Limited.

Please click OK to proceed.